Compounds effecting glucokinase
US7951830B2 · kind B2 · utility
1Cited by
44References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2009 |
| Grant date | May 31, 2011 |
| Priority date | — |
| Expiry date | Feb 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes.The invention also relates to a novel group of compounds of Formula (I) and to methods for preparing compounds of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.